Annual Net Income
-$341.97 M
-$51.46 M-17.72%
December 31, 2023
Summary
- As of February 7, 2025, RLAY annual net profit is -$341.97 million, with the most recent change of -$51.46 million (-17.72%) on December 31, 2023.
- During the last 3 years, RLAY annual net income has fallen by -$289.56 million (-552.47%).
- RLAY annual net income is now -600.98% below its all-time high of -$48.78 million, reached on December 31, 2018.
Performance
RLAY Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$88.11 M
+$4.11 M+4.45%
September 1, 2024
Summary
- As of February 7, 2025, RLAY quarterly net profit is -$88.11 million, with the most recent change of +$4.11 million (+4.45%) on September 1, 2024.
- Over the past year, RLAY quarterly net income has dropped by -$22.37 million (-34.03%).
- RLAY quarterly net income is now -349.76% below its all-time high of $35.28 million, reached on December 31, 2020.
Performance
RLAY Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$345.20 M
-$22.37 M-6.93%
September 1, 2024
Summary
- As of February 7, 2025, RLAY TTM net profit is -$345.20 million, with the most recent change of -$22.37 million (-6.93%) on September 1, 2024.
- Over the past year, RLAY TTM net income has dropped by -$19.22 million (-5.90%).
- RLAY TTM net income is now -2334.06% below its all-time high of -$14.18 million, reached on March 31, 2019.
Performance
RLAY TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
RLAY Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.7% | -34.0% | -5.9% |
| 3 y3 years | -552.5% | -44.8% | -32.2% |
| 5 y5 years | -601.0% | -347.9% | -358.4% |
RLAY Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.7% | +6.0% | -42.0% | +10.6% | -29.2% | +10.0% |
| 5 y | 5-year | -552.5% | +6.0% | -349.8% | +54.4% | -558.6% | +10.0% |
| alltime | all time | -601.0% | +6.0% | -349.8% | +54.4% | -2334.1% | +10.0% |
Relay Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$88.11 M(-4.5%) | -$345.20 M(+6.9%) |
| Jun 2024 | - | -$92.21 M(+13.3%) | -$322.83 M(-1.9%) |
| Mar 2024 | - | -$81.39 M(-2.5%) | -$329.12 M(-3.8%) |
| Dec 2023 | -$341.97 M(+17.7%) | -$83.50 M(+27.0%) | -$341.97 M(+4.9%) |
| Sep 2023 | - | -$65.73 M(-33.3%) | -$325.98 M(-5.4%) |
| Jun 2023 | - | -$98.50 M(+4.5%) | -$344.42 M(+6.7%) |
| Mar 2023 | - | -$94.24 M(+39.6%) | -$322.70 M(+11.1%) |
| Dec 2022 | -$290.51 M(-20.2%) | -$67.50 M(-19.8%) | -$290.51 M(+0.0%) |
| Sep 2022 | - | -$84.17 M(+9.6%) | -$290.46 M(+8.7%) |
| Jun 2022 | - | -$76.79 M(+23.8%) | -$267.12 M(-30.4%) |
| Mar 2022 | - | -$62.05 M(-8.0%) | -$383.73 M(+5.5%) |
| Dec 2021 | -$363.87 M | -$67.46 M(+10.9%) | -$363.87 M(+39.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$60.83 M(-68.5%) | -$261.14 M(+10.5%) |
| Jun 2021 | - | -$193.40 M(+358.5%) | -$236.38 M(+239.1%) |
| Mar 2021 | - | -$42.18 M(-219.6%) | -$69.71 M(+33.0%) |
| Dec 2020 | -$52.41 M(-30.4%) | $35.28 M(-197.8%) | -$52.41 M(-53.0%) |
| Sep 2020 | - | -$36.08 M(+35.0%) | -$111.60 M(+17.2%) |
| Jun 2020 | - | -$26.72 M(+7.4%) | -$95.20 M(+10.7%) |
| Mar 2020 | - | -$24.89 M(+4.1%) | -$86.01 M(+14.2%) |
| Dec 2019 | -$75.31 M(+54.4%) | -$23.91 M(+21.6%) | -$75.31 M(+46.5%) |
| Sep 2019 | - | -$19.67 M(+12.2%) | -$51.39 M(+62.0%) |
| Jun 2019 | - | -$17.54 M(+23.7%) | -$31.72 M(+123.7%) |
| Mar 2019 | - | -$14.18 M | -$14.18 M |
| Dec 2018 | -$48.78 M | - | - |
FAQ
- What is Relay Therapeutics annual net profit?
- What is the all time high annual net income for Relay Therapeutics?
- What is Relay Therapeutics annual net income year-on-year change?
- What is Relay Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Relay Therapeutics?
- What is Relay Therapeutics quarterly net income year-on-year change?
- What is Relay Therapeutics TTM net profit?
- What is the all time high TTM net income for Relay Therapeutics?
- What is Relay Therapeutics TTM net income year-on-year change?
What is Relay Therapeutics annual net profit?
The current annual net income of RLAY is -$341.97 M
What is the all time high annual net income for Relay Therapeutics?
Relay Therapeutics all-time high annual net profit is -$48.78 M
What is Relay Therapeutics annual net income year-on-year change?
Over the past year, RLAY annual net profit has changed by -$51.46 M (-17.72%)
What is Relay Therapeutics quarterly net profit?
The current quarterly net income of RLAY is -$88.11 M
What is the all time high quarterly net income for Relay Therapeutics?
Relay Therapeutics all-time high quarterly net profit is $35.28 M
What is Relay Therapeutics quarterly net income year-on-year change?
Over the past year, RLAY quarterly net profit has changed by -$22.37 M (-34.03%)
What is Relay Therapeutics TTM net profit?
The current TTM net income of RLAY is -$345.20 M
What is the all time high TTM net income for Relay Therapeutics?
Relay Therapeutics all-time high TTM net profit is -$14.18 M
What is Relay Therapeutics TTM net income year-on-year change?
Over the past year, RLAY TTM net profit has changed by -$19.22 M (-5.90%)